Homocysteine (Hcy) follow-up study

Clinical and Investigative Medicine

Volumn 30, Issue 1, 2007, Pages 21-25

  Blum, Arnon ^a,d   Hijazi, Ihsan ^a   Eizenberg, Michal Mashiach ^b   Blum, Nava ^c  

^a Poriya Hospital   (Israel)

^b Emek Yesrael College   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d BARUCH PADEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL EXAMINATION; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT;

EID: 34648813133     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: 10.25011/cim.v30i1.445     Document Type: Article

References (20)

1. Stampfer MJ, Malinow MR, Willer WCet al: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 887-1.
2. Arensen E, Refsum H, Bonna KH, Ueland PM, Forde OH, Norderhaug JE: Serum total homocysteine and coronary artery disease. Int J Epidemiol 1995;24:704-9.
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049-57.
4. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willet WC, Stampler MJ: A prospective study of homocysteine and risk of ischemic stroke. Stroke 1994;25:1924-30.
5. den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. NEJM 1996;334:759-62.
6. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollet SE: Plasma homocysteine concentrations and mortality in patients with coronary artery disease. NEJM 1997;337:320-26.
7. Harker LA, Ross R, Slichter SJ, Scott CR: Homocysteine induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731-41.
8. Wall RT, Harlan JM, Harker LA, Stricker GE: Homocysteine endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980;18:113-21.
9. Parthasarathy S: Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta 1987;917:337-40.
10. Heinecke JW, Rosen H, Suzuki LA, Chait A: The role of sulfur-containing amino acids in superoxide production and modification of low-density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987;262:10098-103.
11. Gardner JE, Slott JH, Ulane RE, schulman JD, Stuart HJ: Effect of homocysteine on platelet and vascular arachidonic acid metabolism. Pediatr Res 1982;16:490-3.
12. McCully KS, Carvalho AC: Homocysteine thiolactone, N-homocysteine thiolactonyl retinamide, and platelet aggregation. Res Commun Chem Pathol 1987; 56: 349-60.
13. Rodgers GM, Kane WH: Activation of endogenous factor V by homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986;77:1909-16.
14. Rodgers GM, Conn MT: Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990;75:895-901.
15. Panganamala RV, Karpen CW, Merola AJ: Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis. Prostaglandins Leukot Med 1986;22:349-56.
16. Shmeleva VM, Kapustin SI, Papayan LP, Sobczynska-Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocystenemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb Res 2003;111:351-6.
17. Iso H, Shinichi S, Kitamura A et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation 2004;109:2766-72.
18. Zylberstein DE, Bengtsson C, Bjorkelund C et al. Serum homocysteine in relation to mortality and morbidity from coronary heart disease. Circulation 2004;109:601-6.
19. Kosar F, Sincer I, Aksoy Y, Ozerol I. Elevated plasma homocysteine concentrations in patients with isolated coronary artery disease. Coronary Artery Dis 2006;17:23-7.
20. Albert CM, Ma J, Rifai N, Stampfer M, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid concentrations as predictors of sudden cardiac death. Circulation 2002;105:2595-600.